eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
5/2010
vol. 14
 
Share:
Share:
abstract:
Review paper

The role of ionotropic glutamate receptors in cancer biology

Andrzej Stepulak
,
Krzysztof Polberg
,
Krzysztof Kupisz
,
Agata Jarząb
,
Aneta Grabarska
,
Witold Jeleniewicz
,
Michał Kiełbus
,
Marta Stryjecka-Zimmer

Współczesna Onkologia (2010) vol. 14; 5 (291–296)
Online publish date: 2010/11/04
View full text Get citation
 
PlumX metrics:
Effective treatment of different types of cancer is limited with regard to the clinical stage of the disease and/or bio­logical properties of the tumour. Be­cause of the low efficacy of traditional chemotherapy, new types of targeted therapy acting selectively on specific metabolic pathways pathologically deregulated in cancer cells are still needed. In the last decade glutamate signalling has emerged as a new potential therapeutic target in cancer. This review outlines the role of gluta­mate as a growth factor for cancer cells, the presence and function of ionotropic glutamate receptors in cancers, and the potential impact of glutamate receptor antagonists as a new generation of cyto­statics. The review also describes suggested mechanisms of their activity at the molecular level.
keywords:

glutamate, ionotropic receptor, cancer, growth factor, targeted therapy

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.